✦ LIBER ✦

A Jak2 inhibitor, AG490, reverses lipin-1 suppression by TNF-α in 3T3-L1 adipocytes

✍ Scribed by Yoshihiro Tsuchiya; Nobuhiko Takahashi; Takayuki Yoshizaki; Sachie Tanno; Masumi Ohhira; Wataru Motomura; Satoshi Tanno; Kaoru Takakusaki; Yutaka Kohgo; Toshikatsu Okumura

Book ID: 117981634
Publisher: Elsevier Science
Year: 2009
Tongue: English
Weight: 411 KB
Volume: 382
Category: Article
ISSN: 0006-291X
DOI: 10.1016/j.bbrc.2009.03.021

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

c-Jun N-terminal kinase is involved in t

c-Jun N-terminal kinase is involved in the suppression of adiponectin expression by TNF-α in 3T3-L1 adipocytes

✍ Kun-yong Kim; Jae Kwang Kim; Jun Ho Jeon; Suk Ran Yoon; Inpyo Choi; Young Yang 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 324 KB

Aucubin, a naturally occurring iridoid g

Aucubin, a naturally occurring iridoid glycoside inhibits TNF-α-induced inflammatory responses through suppression of NF-κB activation in 3T3-L1 adipocytes

✍ Park, Kyoung Sik 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 768 KB

Prostaglandin F2α increases glucose tran

Prostaglandin F2α increases glucose transport in 3T3-L1 adipocytes through enhanced GLUT1 expression by a protein kinase C-dependent pathway

✍ Guang-Yuh Chiou; Jim C. Fong 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 308 KB

Curcumin, a Potential Inhibitor of Up-re

Curcumin, a Potential Inhibitor of Up-regulation of TNF-alpha and IL-6 Induced by Palmitate in 3T3-L1 Adipocytes through NF-kappaB and JNK Pathway

✍ Shao-Ling WANG; Ying LI; Ying WEN; Yan-Feng CHEN; Li-Xin NA; Song-Tao LI; Chang- 📂 Article 📅 2009 🏛 Chinese Electronic Periodical Services 🌐 English ⚖ 335 KB

The adipose tissue triglyceride lipase A

The adipose tissue triglyceride lipase ATGL/PNPLA2 is downregulated by insulin and TNF- in 3T3-L1 adipocytes and is a target for transactivation by PPAR

✍ Kim, J. Y. 📂 Article 📅 2006 🏛 The American Physiological Society 🌐 English ⚖ 871 KB

60 Inhibition of wild type and mutant HI

60 Inhibition of wild type and mutant HIV reverse transcriptases by a new class of non-nucleoside reverse transcriptase inhibitors: H. Zhang1, L. Vrang1, K. Backro2, T. Unge2, P. Engelhardt1, M. Hogberg2, J. Kangasmetsa1, P. Lind1, R. Noreen1, C. Sahlberg1, X.-X. Zhou1, N. G. Johansson1, A. S. Cantrell3, S. R. Jaskunas3, J. M. Morin, Jr.3, R. J. Ternansky3, F. W. Bell3, C. L. Jordan3, M. D. Kinnick3, J. A. Palkowitz3, C. A. Parrish3, P. Pranc3, R. T. Vasileff3, S. J. West3, and B. Oberg1. 1Medivir AB, Huddinge, Sweden; 2Department of Molecular Biology, BMC, Uppsala, Sweden; 3Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, IN, USA

📂 Article 📅 1993 🏛 Elsevier Science 🌐 English ⚖ 57 KB